Biren Amin's Stock Ratings

Piper Sandler Analyst

Biren Amin is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024

Overall Average Return

0.66%

Smart Score

52.4%

Overall Average Return Percentile

39th

Number of Ratings

12
Buy NowGet Alert
07/01/2024SRPTBuy Now
Sarepta Therapeutics
$151.4735.34%$205 → $205MaintainsOverweightGet Alert
06/27/2024CRGXBuy Now
Cargo Therapeutics
$16.20128.4% → $37Initiates → OverweightGet Alert
06/21/2024SLDBBuy Now
Solid Biosciences
$6.70198.51%$20 → $20ReiteratesOverweight → OverweightGet Alert
06/21/2024OCULBuy Now
Ocular Therapeutix
$6.67124.89%$15 → $15MaintainsOverweightGet Alert
06/21/2024SRPTBuy Now
Sarepta Therapeutics
$151.473.65%$157 → $157MaintainsOverweightGet Alert
05/31/2024SRPTBuy Now
Sarepta Therapeutics
$151.473.65% → $157Initiates → OverweightGet Alert
05/31/2024IMNMBuy Now
Immunome
$12.20121.31% → $27Initiates → OverweightGet Alert
05/31/2024ELEVBuy Now
Elevation Oncology
$2.79258.42% → $10Initiates → OverweightGet Alert
05/31/2024APLSBuy Now
Apellis Pharmaceuticals
$37.1123.96% → $46Initiates → NeutralGet Alert
05/31/2024ALLOBuy Now
Allogene Therapeutics
$2.17406.35% → $11Initiates → OverweightGet Alert
05/31/2024ACLXBuy Now
Arcellx
$55.7725.52% → $70Initiates → OverweightGet Alert
05/19/2023ZNTLBuy Now
Zentalis Pharma
$4.201566.75%$120 → $70MaintainsBuyGet Alert